fumagillin

methionyl aminopeptidase 2 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33846894 Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling. 2022 Apr 1
2 34913067 Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry. 2022 Feb 2
3 32252002 Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies. 2020 Jun 2
4 22229417 The development of MetAP-2 inhibitors in cancer treatment. 2012 1
5 23480755 Possible involvement of cyclophilin A processing in fumagillin-induced suppression of cholangiocarcinoma cell proliferation. 2012 1
6 23480758 TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitro. 2012 1
7 17450475 Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target. 2007 1
8 15962312 Methionine aminopeptidases type I and type II are essential to control cell proliferation. 2005 Aug 15 2
9 16004378 Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. 2005 May 2
10 16267007 Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. 2005 Nov 1 2
11 14604668 Design, synthesis and evaluation of a series of novel fumagillin analogues. 2003 Nov 17 1
12 10636239 Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2. 2000 Jan 3 1
13 9860943 Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. 1998 Dec 22 3